My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 144

    1.

    Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis.

    Keino H, Takeuchi M, Usui Y, Hattori T, Yamakawa N, Kezuka T, Sakai JI, Usui M.

    Br J Ophthalmol. 2007 Jan;91(1):105-10. Epub 2006 Aug 30.PMID: 16943228 [PubMed - indexed for MEDLINE]Related articles

    2.

    CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.

    Siepmann K, Biester S, Plsková J, Muckersie E, Duncan L, Forrester JV.

    Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):221-9.PMID: 16741709 [PubMed - indexed for MEDLINE]Related articles

    3.

    Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.

    Kwak HJ, Yang YS, Pae HO, Kim YM, Chung HT.

    Mol Cells. 2001 Oct 31;12(2):178-84.PMID: 11710518 [PubMed - indexed for MEDLINE]Related articles

    4.

    Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.

    Xu H, Strassmann G, Chan CC, Rizzo LV, Silver PB, Wiggert B, Caspi RR.

    Invest Ophthalmol Vis Sci. 1999 Apr;40(5):942-50.PMID: 10102291 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.

    Takeuchi M, Yokoi H, Tsukahara R, Sakai J, Usui M.

    Jpn J Ophthalmol. 2001 Sep-Oct;45(5):463-9.PMID: 11583666 [PubMed - indexed for MEDLINE]Related articles

    6.

    Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.

    Avichezer D, Silver PB, Chan CC, Wiggert B, Caspi RR.

    Invest Ophthalmol Vis Sci. 2000 Jan;41(1):127-31.PMID: 10634611 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.

    Cortes LM, Mattapallil MJ, Silver PB, Donoso LA, Liou GI, Zhu W, Chan CC, Caspi RR.

    Invest Ophthalmol Vis Sci. 2008 May;49(5):1946-56.PMID: 18436827 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice.

    Takeuchi M, Keino H, Kezuka T, Usui M, Taguchi O.

    Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1879-86.PMID: 15161853 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity.

    Grajewski RS, Silver PB, Agarwal RK, Su SB, Chan CC, Liou GI, Caspi RR.

    J Exp Med. 2006 Apr 17;203(4):851-6. Epub 2006 Apr 3.PMID: 16585264 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.

    Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR.

    J Immunol. 1997 Jun 15;158(12):5997-6005.PMID: 9190954 [PubMed - indexed for MEDLINE]Related articles

    11.

    Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.

    Silver PB, Agarwal RK, Su SB, Suffia I, Grajewski RS, Luger D, Chan CC, Mahdi RM, Nickerson JM, Caspi RR.

    J Immunol. 2007 Oct 15;179(8):5146-58.PMID: 17911600 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.

    Keino H, Watanabe T, Sato Y, Niikura M, Wada Y, Okada AA.

    Arthritis Res Ther. 2008;10(5):R122. Epub 2008 Oct 13.PMID: 18847496 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.

    Raveney BJ, Richards C, Aknin ML, Copland DA, Burton BR, Kerr E, Nicholson LB, Williams NA, Dick AD.

    Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4008-17. Epub 2008 May 9.PMID: 18469197 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.

    Tarrant TK, Silver PB, Chan CC, Wiggert B, Caspi RR.

    J Immunol. 1998 Jul 1;161(1):122-7.PMID: 9647215 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Identification of Th2-type suppressor T cells among in vivo expanded ocular T cells in mice with experimental autoimmune uveoretinitis.

    Keino H, Takeuchi M, Suzuki J, Kojo S, Sakai J, Nishioka K, Sumida T, Usui M.

    Clin Exp Immunol. 2001 Apr;124(1):1-8.PMID: 11359436 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.

    Kawashima H, Fujiño Y, Mochizuki M.

    Jpn J Ophthalmol. 1991;35(1):51-60.PMID: 1895569 [PubMed - indexed for MEDLINE]Related articles

    17.

    Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.

    Jiang G, Ke Y, Sun D, Han G, Kaplan HJ, Shao H.

    Invest Ophthalmol Vis Sci. 2008 Jan;49(1):282-9.PMID: 18172104 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.

    Peng Y, Han G, Shao H, Wang Y, Kaplan HJ, Sun D.

    Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4153-61.PMID: 17724201 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Peptide-mediated suppression of experimental autoimmune uveoretinitis in mice: development of a peptide vaccine.

    Kezuka T, Sakai J, Yokoi H, Takeuchi M, Okada A, Taguchi O, Usui M, Mizuguchi J.

    Int Immunol. 1996 Aug;8(8):1229-35.PMID: 8918692 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes.

    Avichezer D, Liou GI, Chan CC, Lewis GM, Wiggert B, Donoso LA, Nickerson JM, Crawford MA, Caspi RR.

    J Autoimmun. 2003 Nov;21(3):185-94.PMID: 14599843 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity